Boston Trust Walden’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.7M Sell
407,243
-2,772
-0.7% -$403K 0.45% 75
2026
Q1
$59.2M Sell
410,015
-10,083
-2% -$1.53M 0.49% 71
2025
Q4
$60.2M Sell
420,098
-8,700
-2% -$1.28M 0.45% 81
2025
Q3
$65.9M Sell
428,798
-83,321
-16% -$13M 0.48% 75
2025
Q2
$81.6M Buy
512,119
+29,796
+6% +$4.86M 0.58% 53
2025
Q1
$82.2M Buy
482,323
+225,389
+88% +$37.8M 0.6% 52
2024
Q4
$43.1M Sell
256,934
-838
-0.3% -$143K 0.3% 135
2024
Q3
$44.6M Sell
257,772
-730
-0.3% -$124K 0.31% 128
2024
Q2
$42.6M Sell
258,502
-5,070
-2% -$829K 0.32% 126
2024
Q1
$42.8M Buy
263,572
+20,895
+9% +$3.28M 0.31% 126
2023
Q4
$35.6M Buy
242,677
+1,121
+0.5% +$166K 0.27% 137
2023
Q3
$35.2M Buy
241,556
+929
+0.4% +$142K 0.3% 122
2023
Q2
$36.5M Buy
240,627
+2,010
+0.8% +$303K 0.3% 123
2023
Q1
$35.5M Sell
238,617
-4,670
-2% -$668K 0.31% 122
2022
Q4
$36.9M Buy
243,287
+1,907
+0.8% +$267K 0.32% 110
2022
Q3
$30.5M Buy
241,380
+6,839
+3% +$972K 0.3% 116
2022
Q2
$33.7M Sell
234,541
-536
-0.2% -$80.6K 0.32% 113
2022
Q1
$35.9M Sell
235,077
-1,402
-0.6% -$219K 0.3% 122
2021
Q4
$38.7M Sell
236,479
-1,327
-0.6% -$197K 0.31% 114
2021
Q3
$33.2M Sell
237,806
-17,322
-7% -$2.46M 0.29% 125
2021
Q2
$34.4M Sell
255,128
-18,088
-7% -$2.45M 0.31% 117
2021
Q1
$37M Sell
273,216
-145,852
-35% -$19M 0.36% 102
2020
Q4
$58.3M Buy
419,068
+265
+0.1% +$37K 0.62% 42
2020
Q3
$58.2M Buy
418,803
+17,306
+4% +$2.3M 0.73% 31
2020
Q2
$48M Buy
401,497
+104,220
+35% +$12.2M 0.65% 39
2020
Q1
$32.7M Sell
297,277
-13,502
-4% -$1.62M 0.52% 52
2019
Q4
$38.8M Sell
310,779
-3,334
-1% -$408K 0.45% 69
2019
Q3
$39.1M Sell
314,113
-12,801
-4% -$1.51M 0.49% 61
2019
Q2
$35.8M Sell
326,914
-1,604
-0.5% -$171K 0.47% 65
2019
Q1
$34.2M Sell
328,518
-5,299
-2% -$516K 0.47% 63
2018
Q4
$30.7M Sell
333,817
-15,270
-4% -$1.37M 0.49% 62
2018
Q3
$29.1M Sell
349,087
-9,166
-3% -$750K 0.4% 74
2018
Q2
$28M Sell
358,253
-40,805
-10% -$3.07M 0.41% 77
2018
Q1
$31.6M Sell
399,058
-16,204
-4% -$1.35M 0.48% 64
2017
Q4
$38.2M Sell
415,262
-48,481
-10% -$4.36M 0.56% 51
2017
Q3
$42.2M Sell
463,743
-33,578
-7% -$3.06M 0.66% 45
2017
Q2
$43.3M Sell
497,321
-17,820
-3% -$1.57M 0.7% 43
2017
Q1
$46.3M Sell
515,141
-57,588
-10% -$5.11M 0.72% 36
2016
Q4
$48.2M Buy
572,729
+338
+0.1% +$28.8K 0.76% 34
2016
Q3
$51.4M Sell
572,391
-4,691
-0.8% -$407K 0.85% 26
2016
Q2
$48.9M Buy
577,082
+7,005
+1% +$575K 0.83% 30
2016
Q1
$46.9M Sell
570,077
-4,928
-0.9% -$397K 0.82% 27
2015
Q4
$45.7M Sell
575,005
-128,283
-18% -$9.8M 0.85% 27
2015
Q3
$50.6M Sell
703,288
-5,176
-0.7% -$388K 0.85% 23
2015
Q2
$55.4M Sell
708,464
-11,654
-2% -$938K 0.85% 21
2015
Q1
$59M Buy
720,118
+1,248
+0.2% +$107K 0.88% 21
2014
Q4
$65.5M Sell
718,870
-6,079
-0.8% -$535K 0.97% 14
2014
Q3
$60.7M Sell
724,949
-2,466
-0.3% -$202K 0.94% 17
2014
Q2
$57.2M Buy
727,415
+202
+0% +$16.3K 0.83% 30
2014
Q1
$58.6M Buy
727,213
+1,276
+0.2% +$101K 0.87% 25
2013
Q4
$59.1M Sell
725,937
-6,426
-0.9% -$524K 0.86% 26
2013
Q3
$55.4M Sell
732,363
-6,694
-0.9% -$533K 0.85% 24
2013
Q2
$56.9M Buy
+739,057
New +$58M 0.92% 18

Other funds holding PG

Boston Trust Walden's PG Position: Q2 2026 in Review

Boston Trust Walden reduced its Procter & Gamble (PG) stake by 0.68% in Q2 2026, selling an estimated $403K and leaving 407,243 shares worth $59.7M. The position accounts for 0.45% of the portfolio, ranked #75.

Boston Trust Walden first reported a position in PG in Q2 2013 and has held it in 53 quarters since. The position peaked at $82.2M in Q1 2025. 1,785 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Boston Trust Walden held 407,243 shares of Procter & Gamble worth $59.7M as of Q2 2026.
  • Boston Trust Walden sold 2,772 Procter & Gamble shares in Q2 2026, an estimated $403K.
  • Procter & Gamble made up 0.45% of Boston Trust Walden's portfolio in Q2 2026, its #75 holding.
  • Boston Trust Walden first reported a position in Procter & Gamble in Q2 2013 and has held it in 53 quarters since.
  • Boston Trust Walden's Procter & Gamble position peaked at $82.2M in Q1 2025.
  • 1,785 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.